AspenBio Pharma Advances BoviPure FSH(TM) Reproduction Drug with FDA Filing and GMP Manufacturing Contract (PR Newswire via Yahoo! Finance)
AspenBio Pharma, Inc. an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, today reported that it has received its INADA file number for BoviPure FSH to officially start the United States Food and Drug Administration approval process.

Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product (Business Wire via Yahoo! Finance)
WOBURN, Mass.----Anika Therapeutics, Inc. today announced that it has received U.S. FDA approval for commercial sale of its corrective and aesthetic dermatology product. This product is licensed to Galderma Pharma, S.A. who will launch it worldwide under its proprietary brand name, ELEVESS.